+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Glucagon Like Peptide 1 Agonist"

Antidiabetics Market Report 2026 - Product Thumbnail Image

Antidiabetics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Semaglutides Market Report 2026 - Product Thumbnail Image

Semaglutides Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Diabetes Care Drugs Market Report 2026 - Product Thumbnail Image

Diabetes Care Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Diabetes Therapeutics Market Report 2026 - Product Thumbnail Image

Diabetes Therapeutics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Oral Antidiabetic Drugs Market Report 2026 - Product Thumbnail Image

Oral Antidiabetic Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Xultophy 100/3.6 Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts - Product Thumbnail Image

Xultophy 100/3.6 Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Next Generation Diabetes Therapy and Drug Delivery Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Thumbnail Image

Next Generation Diabetes Therapy and Drug Delivery Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • January 2026
  • 182 Pages
  • Global
From
Prediabetes Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Thumbnail Image

Prediabetes Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • May 2026
  • 180 Pages
  • Global
From
Oral Anti-Diabetic Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Thumbnail Image

Oral Anti-Diabetic Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • May 2026
  • 185 Pages
  • Global
From
Metabolic Disorders Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Thumbnail Image

Metabolic Disorders Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • May 2026
  • 185 Pages
  • Global
From
Synthetic Hormones Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Thumbnail Image

Synthetic Hormones Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • May 2026
  • 177 Pages
  • Global
From
Diabetes Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Thumbnail Image

Diabetes Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • January 2026
  • 180 Pages
  • Global
From
Antidiabetics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Thumbnail Image

Antidiabetics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • January 2026
  • 181 Pages
  • Global
From
Insulin Resistance Biomarker Panels Global Market Report 2026 - Product Thumbnail Image

Insulin Resistance Biomarker Panels Global Market Report 2026

  • Report
  • May 2026
  • 250 Pages
  • Global
From
Inadequately Controlled Type-II Diabetes Treatment Market Report 2026 - Product Thumbnail Image

Inadequately Controlled Type-II Diabetes Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Type 2 Diabetes Mellitus Treatment Market - Global Strategic Business Report - Product Thumbnail Image

Type 2 Diabetes Mellitus Treatment Market - Global Strategic Business Report

  • Report
  • September 2026
  • 381 Pages
  • Global
From
Diabetic Peripheral Neuropathy - Pipeline Insight, 2026 - Product Thumbnail Image

Diabetic Peripheral Neuropathy - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 180 Pages
  • Global
From
Type 2 Diabetes - Competitive Landscape and Clinical Trial Analysis, 2026 - Product Thumbnail Image

Type 2 Diabetes - Competitive Landscape and Clinical Trial Analysis, 2026

  • Report
  • September 2026
  • 450 Pages
  • Global
From
Type 2 Diabetes Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2034 - Product Thumbnail Image

Type 2 Diabetes Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2034

  • Drug Pipelines
  • September 2026
  • 150 Pages
  • Global
From
Diabetes Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2034 - Product Thumbnail Image

Diabetes Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2034

  • Drug Pipelines
  • September 2026
  • 150 Pages
  • Global
From
Loading Indicator

The Glucagon Like Peptide 1 Agonist (GLP-1) market is a subset of the larger diabetes drugs market. GLP-1 agonists are a class of drugs used to treat type 2 diabetes, and are designed to mimic the effects of the hormone glucagon-like peptide-1 (GLP-1). GLP-1 agonists work by stimulating the release of insulin, reducing the amount of glucose in the blood, and slowing the rate of gastric emptying. GLP-1 agonists are typically administered via injection, and are used in combination with other diabetes medications. The GLP-1 agonist market is highly competitive, with a number of major pharmaceutical companies offering products. These include Novo Nordisk, Eli Lilly, Sanofi, AstraZeneca, and Boehringer Ingelheim. Show Less Read more